The effect of aggressive versus standard lipid lowering by atorvastatin on diabetic dyslipidemia: the DALI study: a double-blind, randomized, placebo-controlled trial in patients with type 2 diabetes and diabetic dyslipidemia

H Jansen; I Berkman-Planken; N Hoogerbrugge; HMG Princen; MV Huisman; MA van de Ree; RP (Ronald) Stolk; FV van Venrooij; JD Banga; GM Dallinga-Thie

The effect of aggressive versus standard lipid lowering by atorvastatin on diabetic dyslipidemia: the DALI study: a double-blind, randomized, placebo-controlled trial in patients with type 2 diabetes and diabetic dyslipidemia

H Jansen, I Berkman-Planken, N Hoogerbrugge, HMG Princen, MV Huisman, MA van de Ree, RP (Ronald) Stolk, FV van Venrooij, JD Banga, GM Dallinga-Thie

Research output: Contribution to journal › Article › Academic › peer-review

138 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1335-1341
Number of pages	7
Journal	Diabetes Care
Volume	24
Publication status	Published - 2001

Research programs

EMC 05-03-21-01-00
EMC 05-03-38-04-00

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Jansen, H., Berkman-Planken, I., Hoogerbrugge, N., Princen, HMG., Huisman, MV., van de Ree, MA., Stolk, RP., van Venrooij, FV., Banga, JD., & Dallinga-Thie, GM. (2001). The effect of aggressive versus standard lipid lowering by atorvastatin on diabetic dyslipidemia: the DALI study: a double-blind, randomized, placebo-controlled trial in patients with type 2 diabetes and diabetic dyslipidemia. Diabetes Care, 24, 1335-1341.

@article{bb9f34fc512140859ca862e937453aa1,

title = "The effect of aggressive versus standard lipid lowering by atorvastatin on diabetic dyslipidemia: the DALI study: a double-blind, randomized, placebo-controlled trial in patients with type 2 diabetes and diabetic dyslipidemia",

author = "H Jansen and I Berkman-Planken and N Hoogerbrugge and HMG Princen and MV Huisman and \{van de Ree\}, MA and Stolk, \{RP (Ronald)\} and \{van Venrooij\}, FV and JD Banga and GM Dallinga-Thie",

year = "2001",

language = "Undefined/Unknown",

volume = "24",

pages = "1335--1341",

journal = "Diabetes Care",

issn = "0149-5992",

publisher = "American Diabetes Association Inc.",

}

Jansen, H, Berkman-Planken, I, Hoogerbrugge, N, Princen, HMG, Huisman, MV, van de Ree, MA, Stolk, RP, van Venrooij, FV, Banga, JD & Dallinga-Thie, GM 2001, 'The effect of aggressive versus standard lipid lowering by atorvastatin on diabetic dyslipidemia: the DALI study: a double-blind, randomized, placebo-controlled trial in patients with type 2 diabetes and diabetic dyslipidemia', Diabetes Care, vol. 24, pp. 1335-1341.

The effect of aggressive versus standard lipid lowering by atorvastatin on diabetic dyslipidemia: the DALI study: a double-blind, randomized, placebo-controlled trial in patients with type 2 diabetes and diabetic dyslipidemia. / Jansen, H; Berkman-Planken, I; Hoogerbrugge, N et al.
In: Diabetes Care, Vol. 24, 2001, p. 1335-1341.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - The effect of aggressive versus standard lipid lowering by atorvastatin on diabetic dyslipidemia: the DALI study: a double-blind, randomized, placebo-controlled trial in patients with type 2 diabetes and diabetic dyslipidemia

AU - Jansen, H

AU - Berkman-Planken, I

AU - Hoogerbrugge, N

AU - Princen, HMG

AU - Huisman, MV

AU - van de Ree, MA

AU - Stolk, RP (Ronald)

AU - van Venrooij, FV

AU - Banga, JD

AU - Dallinga-Thie, GM

PY - 2001

Y1 - 2001

M3 - Article

SN - 0149-5992

VL - 24

SP - 1335

EP - 1341

JO - Diabetes Care

JF - Diabetes Care

ER -